Appropriateness of a 4 mg/kg gentamicin or tobramycin loading dose in post-operative septic shock patients

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 3, 1998, Pages 185-190

  Oparaoji, E C ^a   Siram, S ^b   Shoheiber, O ^a   Cornwell III, E E ^c   Mezghebe, H M ^b  

^a HOWARD UNIVERSITY   (United States)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

^c LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; TOBRAMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; HUMAN; POSTOPERATIVE INFECTION; SEPTIC SHOCK;

ADULT; AGED; ANTI-BACTERIAL AGENTS; FEMALE; GENTAMICINS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SHOCK, SEPTIC; TIME FACTORS; TOBRAMYCIN;

EID: 0031756522     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00126.x     Document Type: Article

References (17)

1. Kreger BE, Craven DE, McCabe NR. (1980) Gram negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. American Journal of Medicine, 68, 344-355.
2. Moore RD, Smith CR, Litman PS. (1984) The association of aminoglycoside plasma levels with mortality in patients with Gram negative bacteremia. Journal of Infectious Diseases, 149, 443-448.
3. Whipple JK, Ausman RK, Franson T, et al. (1991) Effect of individualized pharmacokinetic dosing on patient outcome. Critical Care Medicine, 19, 1480-1485.
4. Oparaoji CE, Cornwell EE, Hekmat E, et al. (1993) Aminoglycoside volume of distribution in post operative patients with septic shock. Clinical Pharmacy, 12, 131-134.
5. Summer WR, Michael JR, Lipsky JJ. (1983) Initial aminoglycoside levels in the critically ill. Critical Care Medicine, 11, 948-950.
6. Knober JE, Anderson PO. (eds) (1993) Handbook of Clinical Drug Data. 7th edn, pp. 338-339. Drug Intelligence Publications Inc., Hamilton, IL.
7. Schering Corporation. (1990) Garamycin package insert. Schering Corporation, Kenilworth, NJ.
8. Lake KD, Peterson CD. (1985) A simplified dosing method for initiating vancomycin therapy. Pharmacology, 5(6), 340-344.
9. Devine B. (1974) Gentamicin therapy. Drug Intelligence and Clinical Pharmacy, 8, 650-655.
10. Zaske DE. (1980) Counterpoint discussion: aminoglycosides. In: Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. Eds Evans WE, Schentag JJ, Jusko WJ, pp. 210-239, Applied Therapeutics Inc, San Francisco.
11. Cockroft DW, Gault MH. (1976) Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31-41.
12. Chelluri L, Warren J, Jastremski MS. (1987) Inadequacy of standard aminoglycoside loading doses in acutely ill patients. Critical Care Medicine, 15, 1143-1145.
13. Dasta JF, Armstrong KD. (1988) Variability in aminoglycoside pharmacokinetics in critically ill patients. Critical Care Medicine, 16, 327-330.
14. Niemec PW, Allo MD, Miller CF. (1987) Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care. Archives of Surgery, 122, 207-212.
15. Martin C, Mallet MN, Saux P, Bruguerolle B, Herat V, Gouin F. (1988) Tobramycin dosing in mechanically ventilated patients: inaccuracy of a 'rule of thumb'. Journal of Antimicrobial Chemotherapy, 22, 505-511.
16. Chelluri L, Warren J, Jastremski MS. (1984) Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients. Chest, 95, 1295-1297.
17. Noone P, Parsons TMC, Pattish JR, et al. (1974) Experience in monitoring gentamicin therapy during treatment of serious Gram negative sepsis. British Medical Journal, 1, 477-481.